Comorbidity and the risk of venous thromboembolism in prostate cancer
A partir des données des registres danois des cancers portant sur 44 035 patients atteints d'un cancer de la prostate diagnostiqué entre 1995 et 2011, et sur 213 810 témoins en population générale, cette étude de cohorte évalue l'association entre un cancer de la prostate, des comorbidités et le risque de maladie thromboembolique veineuse
In this issue, Ording et al use the Danish Cancer Registry to examine the interaction between prostate cancer, comorbidity, and the risk of venous thromboembolism. Their findings suggest that severe comorbidity and prostate cancer interact to synergistically increase the risk of venous thromboembolism, although their small sample and other limitations demand caution in interpreting the findings. See also pages 000-000.
Cancer , éditorial, 2014